Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 August 2021 | Story Department of Communication and Marketing

Dear Student, 

As from today (20 August 2021), all people 18 years and older are eligible to be vaccinated against COVID-19. Register on the COVID-19 Vaccination Programme registration portal to get the vaccine.

Individuals aged 18 and older can get vaccinated at sites  across the country – including the Universitas Academic Hospital in Bloemfontein and retail stores such as Clicks and Dischem.

Remember, you can walk into any vaccination site to register and vaccinate. 

Here is a list of registered vaccination sites closest to the University of the Free State campuses: 
- Boikhuco Old Age Home – Bloemfontein (Mangaung)
- MUCPP Community Health Centre in Rocklands – Bloemfontein (Mangaung)x
- Pelonomi Hospital – Bloemfontein (Mangaung) 
- Standard Bank Building – Bloemfontein (Mangaung)
- Universitas Academic Hospital – Bloemfontein (Mangaung)
- Botshabelo Hospital – Botshabelo (Mangaung)
- Seemahale Secondary School – Botshabelo (Mangaung)
- Dr JS Moroka Hospital – Thaba Nchu (Mangaung)
- Dihlabeng Regional Hospital – Bethlehem, Dihlabeng (Thabo Mofutsanyana)
- Thabo Thokoza Secondary School – Dihlabeng (Thabo Mofutsanyana)
- Thekolohelong Old Age Home – Maluti-A-Phofung (Thabo Mofutsanyana)
- Senorita Nthlabathi District Hospital – Mantsopa (Thabo Mofutsanyana)
- Nketoana District Hospital – Nketoana (Thabo Mofutsanyana)
- Phumelela District Hospital – Phumelela (Thabo Mofutsanyana)

Vaccines are an important part of stopping the spread of COVID-19. Vaccines reduce the risk of getting a disease by working with your body to build protection. 

Need more information on vaccines? Read our COVID-19 Vaccine Information booklet here.

Visit the UFS COVID-19 webpage for updated information. 


News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept